When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Rival manufacturers fight for the right to sell weight loss drugsThere’s a new fight brewing between ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide-based drugs, Ozempic and Wegovy – since 2022 amid unprecedented ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

Health-care costs are going up and and yet, workers may still not get the coverage they want — particularly when it comes to drugs like Ozempic.

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

The 2025 annual Medicare enrollment period runs from Oct. 15 to Dec. 7. Major changes are on the way for beneficiaries next year.

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...